- Recent Funding
- Investors
- Viking Global Investors
Viking Global Investors portfolio
Viking Global Investors has 19 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months.
About this page
It led 11 of the 26 rounds it joined. Its most recent investment on record is TriGemX Bio's $94M funding round in October 2026, alongside TCG Crossover and The Column Group. By category, its portfolio leans toward Health and bio (13) and Data and analytics (4). It has co-invested with GV, Goldman Sachs Asset Management and Andreessen Horowitz, most often GV (6 rounds).
What Viking Global Investors invests in
- Health and bio · 13 · 68%
- Data and analytics · 4 · 21%
- Legal and compliance · 2 · 11%
- Education · 2 · 11%
- Sales and marketing · 2 · 11%
- Commerce and retail · 2 · 11%
- Logistics and mobility · 1 · 5%
- Developer tools and cloud · 1 · 5%
Viking Global Investors recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| round · $94M | TCG Crossover (lead), The Column Group (lead) | ||
| Series B+ · $110M | AlleyCorp, Andreessen Horowitz (lead), Ulysses Capital | ||
| Series B+ · $99.5M · lead | Casdin Capital, Slate Path Capital, ARCH Venture Partners +6 | ||
| Series B+ · $125M · lead | Redmile Group, Qatar Investment Authority, OrbiMed +6 | ||
| Series B+ · $56M | ATHOS KG, Civilization Ventures, Global Health Investment Corporation (lead) +5 | ||
| Series B+ · lead | J.P. Morgan Growth Equity Partners, Alkeon Capital, SoftBank Vision Fund +4 | ||
| Series A · $75M | Access Biotechnology, Maverick Capital, Saturn Partners +6 | ||
| Series B+ · $95M | ARCH Venture Partners, Alpha Wave Global (lead), Jeito Capital +1 |
How Viking Global Investors invests
Viking Global Investors portfolio companies
TTriGemX Bio$94Mround · Oct 2026
PPearl Health$110MSeries B+ · Jul 2026
CCity Therapeutics$99.5MSeries B+ · Jun 2026
SStar Therapeutics$125MSeries B+ · Oct 2025
AAntheia$56MSeries B+ · Jun 2025
AAlphaSenseSeries B+ · Jun 2024
AAreteia Therapeutics$75MSeries A · Feb 2024
HHI-Bio$95MSeries B+ · Jan 2024
LLightmatter$155MSeries B+ · Dec 2023
LLocus Biosciences$35MSeries B+ · May 2022
CCognism$88MSeries B+ · Jan 2022
CCloudbeds$150MSeries B+ · Nov 2021
AApeel Sciences$250MSeries B+ · Aug 2021
IImpossible Foods$300MSeries B+ · May 2019
CCreditKarmabacker
EEnsomabacker
AAsset Watchbacker
BBiomEditbacker
VVelosbiobacker
| Company | Round with Viking Global Investors | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
round · $94M | $94M | Oct 1, 2026 round |
Health and bio |
Series B+ · $110M | $203M | Jul 8, 2026 Series B+ |
Health and bio |
Series B+ · $99.5M · lead | $234.5M | Aug 8, 2026 Series B+ |
Health and bio |
Series B+ · $125M · lead | $415M | Oct 23, 2026 Series B+ |
Legal and compliance |
Series B+ · $56M | $153M | Jan 27, 2026 Series B+ |
Data and analytics |
Series B+ · lead | $830M | Jun 3, 2026 round |
Health and bio |
Series A · $75M | $75M | Feb 13, 2024 Series A |
Health and bio |
Series B+ · $95M | $215M | Jan 4, 2024 Series B+ |
AI infrastructure and compute |
Series B+ · $155M · lead | $800M | Oct 21, 2024 Series B+ |
Health and bio |
Series B+ · $35M | $54M | Feb 16, 2024 Series B+ |
Sales and marketing |
Series B+ · $88M · lead | $116.91M | Jan 13, 2022 Series B+ |
Sales and marketing |
Series B+ · $150M | $244M | Nov 3, 2021 Series B+ |
Commerce and retail |
Series B+ · $250M | $603M | Oct 22, 2025 Series B+ |
Commerce and retail |
Series B+ · $300M | $1.68B | Nov 23, 2021 Series B+ |
Stablecoins |
backer | undisclosed | — |
Health and bio |
backer | $50M | May 16, 2023 Series B+ |
Data and analytics |
backer | undisclosed | Mar 2, 2026 Series B+ |
Health and bio |
backer | undisclosed | Feb 16, 2026 Series B+ |
Health and bio |
backer | $58M | Aug 2, 2026 Series B+ |
Most frequent co-investors
GGV6 shared rounds · last Feb 13, 2024
GGoldman Sachs Asset Management4 shared rounds · last Jun 12, 2024
AAndreessen Horowitz3 shared rounds · last Jul 8, 2026
AARCH Venture Partners3 shared rounds · last Jun 8, 2026
CCapitalG3 shared rounds · last Jun 12, 2024
TTemasek3 shared rounds · last Aug 18, 2021
KKhosla Ventures3 shared rounds · last May 13, 2019
UUBS3 shared rounds · last May 13, 2019
HHorizons Ventures3 shared rounds · last May 13, 2019
BBill Gates3 shared rounds · last May 13, 2019
AAlleyCorp2 shared rounds · last Jul 8, 2026
SSofinnova Partners2 shared rounds · last Jun 8, 2026
Similar investors
EEQT Life Sciences19 companies · 6 deals in 12 mo
Rredalpine19 companies · 5 deals in 12 mo
CCatalio20 companies · 6 deals in 12 mo
EEDBI20 companies · 4 deals in 12 mo
OOxford Science Enterprises18 companies · 11 deals in 12 mo
AAtlas Venture18 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 26 rounds on Recent Funding that name Viking Global Investors. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Viking Global Investors, which is a subset of its real portfolio. API: /api/v1/investors/viking-global-investors (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy